DR

Dilipkumar Rameshbhai Parmar

Active Director Director DIN 11105753
DIN 11105753 First appointment May 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Dilipkumar Rameshbhai Parmar

Data last updated:

Dilipkumar Rameshbhai Parmar is a Director at Vedrishi Healthcare Private Limited (since 2025). The company operates in Healthcare.

DIN 11105753
Primary Designation Director
Industry Healthcare
First Appointment 14 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vedrishi Healthcare Private Limited U21003GJ2025PTC162911
Director14 May 20252025Active

Board colleagues of Dilipkumar Rameshbhai Parmar

Directorship timeline

Open interactive timeline →
Vedrishi Healthcare Private Limited
Premium access

Shareholding and investment profile for Dilipkumar Rameshbhai Parmar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dilipkumar Rameshbhai Parmar

Dilipkumar Rameshbhai Parmar currently holds 1 directorship: Vedrishi Healthcare Private Limited (Director, since 14 May 2025).

Dilipkumar Rameshbhai Parmar was first appointed on 14 May 2025 as Director at Vedrishi Healthcare Private Limited.

The current boards of Dilipkumar Rameshbhai Parmar's companies include Nirmalkumar Rameshbhai Patel (Vedrishi Healthcare Private Limited), Pravinbhai Sajjanbhai Prajapati (Vedrishi Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available